Skip to main content
Premium Trial:

Request an Annual Quote

G. Mason Morfit, Paulette Gray, Robert Negm

Premium

G. Mason Morfit, a partner with ValueAct Capital, will join the board of Solexa, the Hayward, Calif.-based company said last week. Prior to joining ValueAct in 2000, Morfit worked in equity research for Credit Suisse First Boston. He holds a BA from Princeton University.


Paulette Gray has become director of the division of extramural activities of the National Cancer Institute, NCI said last week. She had held positions as the division's acting and deputy director since 1997. The division of extramural activities coordinates all of NCI's extramural programs and grants. Gray joined NCI in 1984 as a special review officer, moving to different positions from there. She holds a PhD in cellular and developmental biology and an MS in mycology from Atlanta University, and a BS in biology from Tuskegee University in Alabama.


Robert Negm has become vice president of business development for GenTel BioSurfaces, the Madison, Wis.-based biochip firm said last week. He comes to GenTel from Whatman Schleicher & Schuell BioScience, where he was director of business development. Prior to that, he was a program director with the National Cancer Institute.

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.